Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
20,831,853
-
Share change
-
+20,831,853
-
Total reported value
-
$320,777,000
-
Price per share
-
$15.40
-
Number of holders
-
36
-
Value change
-
+$320,777,000
-
Number of buys
-
36
Institutional Holders of GRACELL BIOTECHNOLOGIES INC - SPONSORED ADS (GRCL) as of Q1 2021
As of 31 Mar 2021,
GRACELL BIOTECHNOLOGIES INC - SPONSORED ADS (GRCL) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,831,853 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, Vivo Capital, LLC, VIKING GLOBAL INVESTORS LP, FEDERATED HERMES, INC., Capital International Investors, BlackRock Inc., MORGAN STANLEY, CAPITAL INTERNATIONAL INC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This page lists
36
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.